Ana Cambra Conejero, Laura Martínez Figueras, Alicia Ortiz Temprado, Paula Blanco Soto, Álvaro Martín Rivada, Laura Palomino Pérez, Elvira Cañedo Villarroya, Consuelo Pedrón Giner, Pilar Quijada Fraile, Elena Martín-Hernández, María Teresa García Silva, Silvia Chumillas Calzada, Marcello Bellusci, Amaya Belanger-Quintana, Sinziana Stanescu, Mercedes Martínez-Pardo Casanova, Ana Moráis López, Ana Bergua Martínez, Pedro Ruiz-Salas, Belén Pérez González, Magdalena Ugarte, Miguel L F Ruano
OBJECTIVE: Tandem mass spectrometry (MS/MS) is being used for newborn screening since this laboratory testing technology increases the number of metabolic disorders that can be detected from dried blood-spot specimens. In the Community of Madrid, it was implemented in March 2011 and it includes 13 aminoacidopathies, fatty acid oxidation disorders and organic acidemias. The aim of this study was to describe our experience and evaluate the screening positive cases in a period of 9 years (2011-2019)...
December 16, 2020: Revista Española de Salud Pública